CūtisCare Launches Second Annual National Hyperbaric Aware™ Campaign to Increase Awareness of Hyperbaric Oxygen Therapy

Hyperbaric oxygen therapy (HBOT) is a proven treatment option for wounds, infections, or injuries that have not responded to standard treatment. There are currently fourteen indications for HBOT recognized by the Centers for Medicare and Medicaid Services (CMS) and other third-party payers. Hyperbaric oxygen therapy is most commonly used for the treatment of diabetic lower extremity ulcers, bone or tissue radiation damage, compromised grafts and flaps, and chronic refractory osteomyelitis.

Hyperbaric Awareness USA™ has designated May as Hyperbaric Awareness Month. Throughout this month (and beyond), the Hyperbaric Aware™ campaign aims to promote the benefits of hyperbaric oxygen therapy, which will help people prolong life, reduce amputations and lower the cost of care while improving the quality of life.

There are more than eight million people in United States who live with chronic wounds. Twenty-five percent of the 34 million people with diabetes in the United States will develop a foot ulcer, which can lead to amputation. Hyperbaric oxygen therapy provides necessary oxygenation, essential to prevent amputation.

In the United States, nearly half of the 17 million people diagnosed with cancer will receive radiation therapy and 10-15% will experience late effects from radiation therapy. Many patients who undergo radiation therapy discover a hidden complication that may not reveal itself until years after treatment has finished. Radiation therapy can restrict the supply of oxygen to healthy body tissues that is needed for their development. If there is a break in the integrity of the tissue, infection and non-healing wounds can occur. Hyperbaric oxygen therapy is a treatment option for patients who suffer from late radiation tissue damage stimulating the growth of new blood vessels as a result of radiation-induced injury.

CūtisCare Chairman of the Board and CEO JimPatrick said, “As an industry leader, we are addressing the lack of awareness of hyperbaric oxygen therapy, an essential modality for chronic wound healing and limb preservation.

The Hyperbaric Aware website, in collaboration with the Undersea and Hyperbaric Medical Society (UHMS) and leading doctors, will share articles, the latest research and expert advice for doctors, patients and the general public.

About CutisCare

Based in Boca Raton, Florida, CūtisCare works with hospitals, academic medical centers, hospital systems and physicians to design customized ambulatory wound care and hyperbaric oxygen (HBOT) solutions. With over 25 years of management experience, a commitment to research, and guided by ethics and a culture of compliance, CūtisCare works with partners to reach and heal people with chronic wounds.

For more information, visit https://cutiscareusa.com and http://hyperbaricaware.com

follow us CutisCare LLC | LinkedIn and Hyperbaric Awareness|LinkedIn.

Media Contact:
Kelly Caceres
[email protected]
904-446-0708

SOURCE CutisCare LLC